NPPB | Natriuretic peptide B | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MYBPC3 | Myosin binding protein C, cardiac | Disease related genes Plasma proteins
| | | | | Tissue enriched |
MYL7 | Myosin, light chain 7, regulatory | | | | | | Tissue enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNNI3 | Troponin I type 3 (cardiac) | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
LRRC10 | Leucine rich repeat containing 10 | Cytoskeleton related proteins
| | | | | Tissue enriched |
NKX2-5 | NK2 homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
TNNT2 | Troponin T type 2 (cardiac) | Candidate cardiovascular disease genes Disease related genes
| | | | | Tissue enriched |
ANKRD1 | Ankyrin repeat domain 1 (cardiac muscle) | Disease related genes
| | | | | Tissue enriched |
RD3L | Retinal degeneration 3-like | | | | | | Tissue enriched |
BMP10 | Bone morphogenetic protein 10 | Predicted secreted proteins
| | | | | Tissue enriched |
NMRK2 | Nicotinamide riboside kinase 2 | Enzymes
| | | | | Group enriched |
SBK2 | SH3 domain binding kinase family, member 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
SCN5A | Sodium channel, voltage-gated, type V, alpha subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TECRL | Trans-2,3-enoyl-CoA reductase-like | Predicted membrane proteins
| | | | | Tissue enriched |
FBXO40 | F-box protein 40 | Plasma proteins
| | | | | Group enriched |
HRC | Histidine rich calcium binding protein | Predicted secreted proteins
| | | | | Group enriched |
C10orf71 | Chromosome 10 open reading frame 71 | | | | | | Group enriched |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
FSD2 | Fibronectin type III and SPRY domain containing 2 | | | | | | Group enriched |
TTN | Titin | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
MYPN | Myopalladin | Disease related genes
| | | | | Group enriched |
KLHL38 | Kelch-like family member 38 | | | | | | Group enriched |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |
KCNJ4 | Potassium inwardly-rectifying channel, subfamily J, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
COX6A2 | Cytochrome c oxidase subunit VIa polypeptide 2 | Mitochondrial proteins Transporters
| | | | | Group enriched |
RPL3L | Ribosomal protein L3-like | Ribosomal proteins
| | | | | Group enriched |
LRRC14B | Leucine rich repeat containing 14B | | | | | | Group enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
C14orf180 | Chromosome 14 open reading frame 180 | Predicted membrane proteins
| | | | | Group enriched |
DHRS7C | Dehydrogenase/reductase (SDR family) member 7C | Predicted secreted proteins
| | | | | Group enriched |
MYBPHL | Myosin binding protein H-like | | | | | | Tissue enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
SMPX | Small muscle protein, X-linked | Disease related genes
| | | | | Group enriched |
FITM1 | Fat storage-inducing transmembrane protein 1 | Predicted membrane proteins
| | | | | Group enriched |
LMOD2 | Leiomodin 2 (cardiac) | Cytoskeleton related proteins
| | | | | Group enriched |
CMYA5 | Cardiomyopathy associated 5 | | | | | | Group enriched |
MYL4 | Myosin, light chain 4, alkali; atrial, embryonic | Plasma proteins
| | | | | Tissue enriched |
SRL | Sarcalumenin | Predicted secreted proteins
| | | | | Group enriched |
TRIM63 | Tripartite motif containing 63, E3 ubiquitin protein ligase | | | | | | Group enriched |
UNC45B | Unc-45 homolog B (C. elegans) | | | | | | Group enriched |
LRRC39 | Leucine rich repeat containing 39 | | | | | | Group enriched |
SMCO1 | Single-pass membrane protein with coiled-coil domains 1 | | | | | | Group enriched |
TRIM54 | Tripartite motif containing 54 | | | | | | Group enriched |
LMOD3 | Leiomodin 3 (fetal) | Cytoskeleton related proteins
| | | | | Group enriched |
MYL2 | Myosin, light chain 2, regulatory, cardiac, slow | Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
KCNIP2 | Kv channel interacting protein 2 | | | | | | Group enriched |